Hans Loibner Selected Research

Hans Loibner Research Topics

Disease

10	Neoplasms (Cancer) 01/2018 - 02/2004
8	Neuroblastoma 11/2023 - 01/2016
4	Pain (Aches) 11/2023 - 01/2018
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2018 - 02/2010
2	Pulmonary Hypertension 12/2018 - 02/2010
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2018 - 01/2016
2	Breast Neoplasms (Breast Cancer) 12/2015 - 02/2004
2	Inflammation (Inflammations) 10/2013 - 02/2011
2	Hypoxia (Hypoxemia) 03/2012 - 02/2010
2	Fibrosis (Cirrhosis) 02/2011 - 08/2010
2	Hypertrophy 01/2011 - 08/2010
1	Capillary Leak Syndrome 12/2018
1	Fever (Fevers) 12/2018
1	Heart Failure 12/2018
1	Hypersensitivity (Allergy) 12/2018
1	Infections 12/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2018
1	Mycoses (Diseases, Fungus) 12/2018
1	Melanoma (Melanoma, Malignant) 10/2018
1	Colonic Neoplasms (Colon Cancer) 10/2013
1	Pulmonary Arterial Hypertension 03/2012
1	Experimental Melanoma 01/2012
1	Lung Injury 02/2010
1	Acute Lung Injury 02/2010
1	Hypertension (High Blood Pressure) 01/2010
1	Carcinoma (Carcinomatosis) 02/2004

Drug/Important Bio-Agent (IBA)

7	dinutuximabIBA 11/2023 - 01/2016
6	Angiotensin-Converting Enzyme 2IBA 03/2012 - 01/2010
5	CytokinesIBA 11/2023 - 06/2007
5	Interleukin-2 (IL2)IBA 01/2019 - 01/2016
4	Angiotensin IIIBA 03/2012 - 01/2010
3	Immunoglobulin G (IgG)IBA 01/2018 - 03/2006
3	Proteins (Proteins, Gene)FDA Link 03/2012 - 03/2006
3	CarbohydratesIBA 06/2007 - 11/2005
3	Conjugate VaccinesIBA 06/2007 - 11/2005
3	AntigensIBA 06/2007 - 11/2005
2	Monoclonal AntibodiesIBA 11/2022 - 12/2018
2	Morphine (MS Contin)FDA LinkGeneric 10/2018 - 01/2018
1	Isotretinoin (Accutane)FDA LinkGeneric 11/2023
1	ganglidiomabIBA 11/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2018
1	lorukafusp alfaIBA 10/2018
1	Therapeutic UsesIBA 01/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018
1	OligodeoxyribonucleotidesIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 10/2013
1	Oxygen (Dioxygen)IBA 03/2012
1	GasesIBA 03/2012
1	Cancer VaccinesIBA 01/2012
1	Small Interfering RNA (siRNA)IBA 01/2012
1	Phosphotransferases (Kinase)IBA 02/2011
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2011
1	Protein Kinase CIBA 02/2011
1	ProcollagenIBA 02/2011
1	CollagenIBA 02/2011
1	Mitogen-Activated Protein Kinase 3IBA 01/2011
1	JNK Mitogen-Activated Protein KinasesIBA 01/2011
1	AngiotensinsIBA 01/2011
1	Telmisartan (Micardis)FDA Link 01/2011
1	Profilins (Profilin)IBA 01/2011
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2011
1	Procollagen Type IIBA 08/2010
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 08/2010
1	Collagen Type III (Type III Collagen)IBA 08/2010
1	Fibronectins (Fibronectin)IBA 08/2010
1	Superoxides (Superoxide)IBA 08/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2010
1	LipopolysaccharidesIBA 02/2010
1	saponin QA-21V1 (QS21)IBA 06/2007
1	Cytotoxins (Cytolysins)IBA 01/2007
1	MucinsIBA 11/2005
1	EpitopesIBA 11/2005
1	ErbB Receptors (EGF Receptor)IBA 02/2004
1	Growth Factor ReceptorsIBA 02/2004
1	SugarsIBA 02/2004
1	Epidermal Growth Factor (EGF)IBA 02/2004
1	OligosaccharidesIBA 02/2004

Therapy/Procedure

10	Immunotherapy 11/2023 - 05/2004
4	Therapeutics 01/2018 - 05/2004
2	Drug Therapy (Chemotherapy) 12/2015 - 05/2004
1	Aftercare (After-Treatment) 12/2018
1	Segmental Mastectomy (Lumpectomy) 12/2015
1	Catheters 03/2012
1	Critical Care (Surgical Intensive Care) 02/2010
1	Radiotherapy 05/2004